Epinephrine inhalation

Phase 1Small molecule

AAmphastar Pharmaceuticals, Inc.

Epinephrine inhalation is one of 19 small molecule programs targeting Tachypnea. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

TachypneaActive, not recruiting

AsthmaActive, not recruiting

TachypneaPhase 1

Active, not recruiting

AsthmaPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Singulair

AstraZeneca

Preclinical

17 2

Cinqair

Teva

Preclinical

13 3

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8 4

Arcoxia

Symbicort

6 6

Atrovent

Boehringer Ingelheim

Preclinical

2 7

Tylenol

KKenvue Brands

Preclinical

1 8

Aclidinium Bromide

AstraZeneca

Preclinical

—9

Epinephrine inhalation

AAmphastar Pharmaceuticals, Inc.

Phase 1

4 10

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma4 trials

Safety Study in Adolescent and Adult Patients With Asthma

Completed·AAmphastar Pharmaceuticals, Inc.·Phase 3·NCT01476904·208 enrolled

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

Completed·AAmphastar Pharmaceuticals, Inc.·Phase 3·NCT01737905·28 enrolled

Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients

Completed·AAmphastar Pharmaceuticals, Inc.·Phase 3·NCT01357642·373 enrolled

Show 1 more trial

Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.

Terminated·AAmphastar Pharmaceuticals, Inc.·Phase 1/2·NCT01025648·9 enrolled

Tics2 trials

Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers

Completed·AAmphastar Pharmaceuticals, Inc.·Phase 1/2·NCT01143051·24 enrolled

Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics

Completed·AAmphastar Pharmaceuticals, Inc.·Phase 1/2·NCT01188577·23 enrolled

Adult1 trial

Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults

Terminated·AAmphastar Pharmaceuticals, Inc.·Phase 1/2·NCT01737892·21 enrolled

Tachypnea1 trial

Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)

Completed·AAhmed Noaman·Phase 1·NCT05006235·135 enrolled

Nasotracheal Intubation1 trial

Epinephrine Nebulization Prior to Nasotracheal Intubation

Completed·—·Phase 3·NCT05738564·126 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Epinephrine inhalation. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Epinephrine inhalation compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Epinephrine inhalation. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Amphastar Pharmaceuticals, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: AAmphastar Pharmaceuticals, Inc.

Epinephrine inhalation

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Asthma4 trials

Tics2 trials

Adult1 trial

Tachypnea1 trial

Nasotracheal Intubation1 trial

References

Drug Info

Quick Facts

Related News